Press release
Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Anticipated To Witness Robust Growth, Surpassing $18.54 Billion By 2029
Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market
What Is the Current Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Size and Its Estimated Growth Rate?
The cell and gene therapy contract development and manufacturing organization (CDMO) market has grown exponentially. It is forecast to increase from $5.41 billion in 2024 to $6.94 billion in 2025, at a CAGR of 28.2%. This growth is fueled by technological advancements, favorable regulatory frameworks, increased investment, a high prevalence of genetic disorders, and a rise in strategic partnerships.
The cell and gene therapy contract development and manufacturing organization (CDMO) market is expected to grow exponentially, reaching $18.54 billion by 2029, at a CAGR of 27.8%. Growth is due to expanded therapeutic applications, regulatory changes, investments, and global collaboration. Trends include personalized therapy demand, automation, manufacturing capacity growth, novel delivery systems, and sustainability focus.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15753
How Are Emerging Segments Shaping the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Landscape?
The cell and gene therapy contract development and manufacturing organization (CDMO) market covered in this report is segmented -
1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy
2) By Phase: Phase 1, Phase 2, Phase 3, Phase 4
3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, Plasmid DNA-Based Gene Therapy
2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy, TCR-T Cell Therapy, NK Cell Therapy
3) By Cell Therapy: Stem Cell Therapy, Progenitor Cell Therapy, Immune Cell Therapy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15753&type=smp
Which Growth Factors Are Influencing Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Expansion?
The increasing incidence of cancer is expected to boost the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market. The rise in cancer cases is due to aging populations, changing lifestyles, environmental exposures, and enhanced diagnostic methods. CDMOs support cancer treatment development by producing targeted therapies that improve effectiveness and patient outcomes. According to a 2022 report by Macmillan Cancer Support, the number of people living with cancer in the UK is projected to grow significantly, reaching 5.3 million by 2040. This increase in cancer prevalence is contributing to the growth of the CDMO market.
Who Are the Dominant Players Across Different Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Segments?
Major companies operating in the cell and gene therapy contract development and manufacturing organization (CDMO) market are Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Ajinomoto Co Inc., Lonza Group, Catalent Inc., Charles River Laboratories International Inc., Sartorius Stedim Biotech, Samsung Biologics Co Ltd., WuXi Biologics, Recipharm AB, Almac Group Ltd., KBI Biopharma, Rentschler Biopharma, Bio Elpida, Oxford BioMedica Plc, Avid Bioservices Inc., Cell and Gene Therapy Catapult, VGXI Inc., Genezen Laboratories Inc., Pluri Inc., OmniaBio Inc.
What Trends Are Expected to Dominate the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market in the Next 5 Years?
Companies in the cell and gene therapy contract development and manufacturing organization (CDMO) market are expanding their offerings with advanced solutions like PluriMatrix technology to improve scalability, efficiency, and quality in cell-based product manufacturing. PluriMatrix facilitates 3D cell expansion, ensuring high yield and quality. In January 2024, Pluri launched PluriCDMO, a division offering cell therapy manufacturing services, including a GMP-compliant production facility. This division leverages PluriMatrix technology to provide end-to-end services in cell therapy production.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-contract-development-and-manufacturing-organization-cdmo-global-market-report
Which Geographic Regions Are Expected to Dominate the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market in the Coming Years?
North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
2. What is the CAGR expected in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
3. What Are the Key Innovations Transforming the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Industry?
4. Which Region Is Leading the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Anticipated To Witness Robust Growth, Surpassing $18.54 Billion By 2029 here
News-ID: 4034891 • Views: …
More Releases from The Business Research Company
Chip Resistor Market Anticipated To Witness Robust Growth, Surpassing $2 Billion …
The Chip Resistor Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Chip Resistor Market Size and Its Estimated Growth Rate?
The chip resistor market size has experienced strong growth in recent years. It will grow from $1.44 billion in 2024 to $1.55…
Biofuel Enzymes Market Size Projected To Reach $2.64 Billion By 2034 With A Cagr …
The Biofuel Enzymes Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Biofuel Enzymes Market?
The biofuel enzymes market has seen robust growth in recent years. It is expected to grow from $1.73 billion in 2024 to $1.89 billion in…
Central Venous Catheters Market Forecast 2025-2034: Comprehensive Analysis And G …
The Central Venous Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Central Venous Catheters Market?
The central venous catheters market size has grown significantly in recent years. It will rise from $3.94 billion in 2024 to $4.31 billion…
Growing Cancer Rates Propel Demand For Home-Based Chemotherapy Services: An Emer …
The Chemotherapy At Home Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Chemotherapy At Home Services Market?
The chemotherapy at home services market size has grown rapidly in recent years. It will grow from $1.75 billion in 2024…
More Releases for Therapy
Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created…
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023.
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand…
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market.
Factors that are likely to hamper the growth of the market…
